CN110169927A - A kind of pulvis of active cell - Google Patents
A kind of pulvis of active cell Download PDFInfo
- Publication number
- CN110169927A CN110169927A CN201910481041.XA CN201910481041A CN110169927A CN 110169927 A CN110169927 A CN 110169927A CN 201910481041 A CN201910481041 A CN 201910481041A CN 110169927 A CN110169927 A CN 110169927A
- Authority
- CN
- China
- Prior art keywords
- phthalein
- pulvis
- few
- cell
- skin
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/33—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
- A61K8/34—Alcohols
- A61K8/345—Alcohols containing more than one hydroxy group
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/64—Proteins; Peptides; Derivatives or degradation products thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/64—Proteins; Peptides; Derivatives or degradation products thereof
- A61K8/65—Collagen; Gelatin; Keratin; Derivatives or degradation products thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/72—Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds
- A61K8/73—Polysaccharides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q19/00—Preparations for care of the skin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q19/00—Preparations for care of the skin
- A61Q19/02—Preparations for care of the skin for chemically bleaching or whitening the skin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q19/00—Preparations for care of the skin
- A61Q19/08—Anti-ageing preparations
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2800/00—Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
- A61K2800/80—Process related aspects concerning the preparation of the cosmetic composition or the storage or application thereof
- A61K2800/84—Products or compounds obtained by lyophilisation, freeze-drying
Abstract
The invention discloses a kind of pulvis of active cell, are prepared by the material of following weight ratio: deionized water 95.99-87.38, mannitol 2-8, pulullan polysaccharide 0.5-0.8, -1 0.1-0.8 of few phthalein, -3 0.3-0.8 of few phthalein, carnosine 0.1-0.2, soluble collagen 1-2, haemocyanin 0.01-0.02.The present invention utilizes modern high technology biotechnology, directly acts on the damaged cell of human body, damaged cell is made to be activated again, provide for skin and endlessly repair power；Do not need as sodium hyaluronate operation repeatedly, will not embolism, less have crosslinking agent embolic risk.
Description
Technical field
The present invention relates to technical field of skin care, and in particular to a kind of pulvis of active cell.
Background technique
As the raising of people 's material life level and the requirement to skin care, beauty are higher and higher, cell activator class
Cosmetics are increasingly becoming one of hot spot of research and development.People get used to largely using and contain hexichol first during skin care, beauty
Inorganic dose of ketone, dibenzoyl methane, benzotriazole etc., result can cause to block pore, cause cutaneous lesions, also some products
Formula because excessively using ultraviolet absorbing agent due to lead to skin allergy, seriously destroy the n cell activation function of human body.And
Cell-stimulating will follow skin organic growth rule, need the time.
Summary of the invention
The object of the present invention is to provide a kind of pulvis of active cell, using modern high technology biotechnology, directly act on
In the damaged cell of human body, damaged cell is made to be activated again, is provided for skin and endlessly repair power；It does not need as glass
Uric acid it is the same repeatedly operation, will not embolism, less have crosslinking agent embolic risk.
In order to solve the above technical problems, the present invention adopts the following technical scheme:
A kind of pulvis of active cell, is prepared by the material of following weight ratio:
Deionized water 95.99-87.38, mannitol 2-8, pulullan polysaccharide 0.5-0.8, -1 0.1-0.8 of few phthalein, widow
- 3 0.3-0.8 of phthalein, carnosine 0.1-0.2, soluble collagen 1-2, haemocyanin 0.01-0.02.
A kind of production method of the pulvis of active cell, comprising:
Step 1: it the selection of raw material and prepares ratio: choosing the tap water by distillation and sterilization processing, mannose
Alcohol, pulullan polysaccharide, oligopeptides -1, carnosine, soluble collagen can be before carrying out mixing match in vacuum packaging；
Step 2: by the quality proportioning weigh mannitol, pulullan polysaccharide, oligopeptides -1, carnosine, soluble collagen,
It is placed in deionized water, then mixture is placed in mixing plant and is at the uniform velocity stirred, be to be stirred in 600r/min in revolving speed
10min, stirring form mixed solution A；
Step 3: mixed solution A standing is again placed in mixing plant afterwards for 24 hours and is at the uniform velocity stirred, is in revolving speed
20min is stirred in 1200r/min；
Step 4: mixed solution A is filtered by filter membrane, is removed impurity not soluble in water in mixed solution A and is obtained
To mixed solution B；
Step 5: filling be placed in centrifugation apparatus in 7ml ampulla of mixed solution B is subjected to centrifugally operated, is then carried out
Precooling operation, at this time temperature control carry out refrigeration operation, mixed solution B lyophilization, temperature after the completion of -5 DEG C, precooling
Ultraviolet sterilization need to be passed through by controlling the mixed liquor after -15 DEG C, lyophilization；
Step 6: the ampulla freeze-dried powder after lyophilization is placed in sterilizing vacuum environment and carries out vacuum packaging encapsulation, saves
Temperature control is at 0 DEG C hereinafter, obtaining bottled freeze-dried powder.
The beneficial effects of the present invention are: modern high technology biotechnology is utilized, the damaged cell of human body is directly acted on,
So that damaged cell is activated again, is provided for skin and endlessly repair power；Do not need as sodium hyaluronate operation repeatedly,
Will not embolism, less have crosslinking agent embolic risk.
Specific embodiment
Below in conjunction with embodiment, technical scheme in the embodiment of the invention is clearly and completely described, it is clear that institute
The embodiment of description is only a part of the embodiment of the present invention, instead of all the embodiments.Based on the embodiments of the present invention,
Every other embodiment obtained by those of ordinary skill in the art without making creative efforts, belongs to this hair
The range of bright protection.
Embodiment 1
A kind of pulvis of active cell, is prepared by the material of following weight ratio:
Water 87.38, mannitol 8, pulullan polysaccharide 0.8, few phthalein -1 0.8, few phthalein -3 0.8, carnosine 0.2, solubility
Collagen 2, haemocyanin 0.02.
Embodiment 2
A kind of pulvis of active cell, is prepared by the material of following weight ratio:
Water 91.585, mannitol 5, pulullan polysaccharide 0.6, few phthalein -1 0.5, few phthalein -3 0.6, carnosine 0.2, solubility
Collagen 1.5, haemocyanin 0.015.
Embodiment 3
A kind of pulvis of active cell, is prepared by the material of following weight ratio:
Water 95.99, mannitol 2, pulullan polysaccharide 0.5, few phthalein -1 0.1, few phthalein -3 0.3, carnosine 0.1, solubility
Collagen 1, haemocyanin 0.01.
Use case analysis:
Investigate the time: August 31st -2018 years on the 1st March in 2018；Target of investication and study: there are the groups of skin depressions puzzlement；
Target of investication and study age bracket: 35-50；Finding: investigating 20 triers altogether, wherein there is 12 skins thoroughly to be improved, becomes
Obtain full compact, Q bullet；There are also 6 skin change significant effects, become pale bright；Also there is certain effect in other 2.
Liu, female, 38 years old, housewife, face had recess, black eye serious；After having tried out this product 1 month, skin
Skin starts to become pale, while black eye is mitigated；After continuously having tried out this product 2 months, skin becomes full compact, Q
Bullet.
Shao so-and-so, female, 45 years old, secondary school teachers had significant depressions at the cheekbone of left side；After continuously having tried out this product 3 months,
Become at the cheekbone of the left and right sides full and symmetrical.
Active peptide contained by this product, cell active factor etc. are to pass through gene weight using modern high technology biotechnology
Group and generate, directly act on the damaged cell of human body, be reactivated damaged cell, provided endlessly for skin
Maintenance power, first stage repair subcutaneous tissue, and second stage repairs skin corium and flesh bottom.
Obviously, various changes and modifications can be made to the invention without departing from essence of the invention by those skilled in the art
Mind and range.In this way, if these modifications and changes of the present invention belongs to the range of the claims in the present invention and its equivalent technologies
Within, then the present invention is also intended to include these modifications and variations.
Claims (1)
1. a kind of pulvis of active cell, which is characterized in that be prepared by the material of following weight ratio: deionized water 95.99-
87.38, mannitol 2-8, pulullan polysaccharide 0.5-0.8, -1 0.1-0.8 of few phthalein, -3 0.3-0.8 of few phthalein, carnosine 0.1-
0.2, soluble collagen 1-2, haemocyanin 0.01-0.02.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201910481041.XA CN110169927A (en) | 2019-06-04 | 2019-06-04 | A kind of pulvis of active cell |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201910481041.XA CN110169927A (en) | 2019-06-04 | 2019-06-04 | A kind of pulvis of active cell |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CN110169927A true CN110169927A (en) | 2019-08-27 |
Family
ID=67697823
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN201910481041.XA Pending CN110169927A (en) | 2019-06-04 | 2019-06-04 | A kind of pulvis of active cell |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN110169927A (en) |
Cited By (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN110585058A (en) * | 2019-10-24 | 2019-12-20 | 陈文前 | Freeze-dried powder capable of repairing and nourishing skin and preparation method thereof |
Citations (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN107007485A (en) * | 2017-04-06 | 2017-08-04 | 广州丽彦妆生物科技有限公司 | A kind of freeze-dried powder suitable for skin repair |
-
2019
- 2019-06-04 CN CN201910481041.XA patent/CN110169927A/en active Pending
Patent Citations (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN107007485A (en) * | 2017-04-06 | 2017-08-04 | 广州丽彦妆生物科技有限公司 | A kind of freeze-dried powder suitable for skin repair |
Cited By (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN110585058A (en) * | 2019-10-24 | 2019-12-20 | 陈文前 | Freeze-dried powder capable of repairing and nourishing skin and preparation method thereof |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| Yu et al. | Effects of 3-dimensional bioprinting alginate/gelatin hydrogel scaffold extract on proliferation and differentiation of human dental pulp stem cells | |
| CN104189957B (en) | Fresh pig cornea is utilized to prepare method and the application of tissue engineering comea carrier bracket | |
| CN110548002A (en) | Human-derived stem cell exosome composition for resisting skin aging | |
| CN106902381A (en) | Recombination human source collagen stoste, dressing and their preparation method | |
| CN102357259A (en) | Bioprotein sponge and preparation method thereof | |
| CN105816414A (en) | Yeast water and preparation method as well as application thereof to cosmetics | |
| CN108619086A (en) | A kind of Cellular gels preparation for treating tissue damage and application thereof and the active gel solution of holding freeze-stored cell used | |
| CN112662718A (en) | Preparation method of oligomeric sodium hyaluronate | |
| CN111068116A (en) | Cartilage repair temperature-sensitive gel for injection and preparation method thereof | |
| CN107184493A (en) | One kind repairs elite formula of liquid and preparation method thereof | |
| WO2016100411A2 (en) | Collagenous tissue repair device | |
| CN111228130A (en) | Composition with skin cell energy stimulating and skin barrier repairing effects and preparation method and application thereof | |
| CN104745664A (en) | Preparation process of animal placenta extract | |
| CN102861360A (en) | Neural restoration promoting material as well as preparation method and application thereof | |
| CN109157676A (en) | A kind of preparation method for remolding compound bio amnion | |
| CN110169927A (en) | A kind of pulvis of active cell | |
| CN106491439A (en) | A kind of anti-acne essence compositionss, anti-acne essence and preparation technology | |
| CN110387068B (en) | Dendrobium polysaccharide nanocellulose hydrogel | |
| US20190184064A1 (en) | Composition for Soft Tissue Augmentation Providing Protection from Infection | |
| CN110251442A (en) | Cell repair Essence | |
| KR102141095B1 (en) | Use of Mimosa pudica extracts for manufacture of composition for inhibiting MMP2 gene expression and collagen degradation | |
| US20220287952A1 (en) | Compositions containing exosomes from animal placenta, methods for producing the same and uses thereof | |
| CN1289062C (en) | Cosmetic material | |
| CN109288754A (en) | A kind of Essence and preparation method containing persimmon leaf extractive from fermentative | |
| CN109939262A (en) | A kind of preparation method and applications of bFGF hydrogel |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| PB01 | Publication | ||
| PB01 | Publication | ||
| SE01 | Entry into force of request for substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| RJ01 | Rejection of invention patent application after publication |
Application publication date: 20190827 |
|
| RJ01 | Rejection of invention patent application after publication |